| SC 13G/A | 2021-02-17 | Consonance Capital Management LP | ARQULE INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-16 | Consonance Capital Management LP | ARQULE INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | ARQULE INC | 2,471,860 | 1.3% | EDGAR |
| SC 13G | 2020-02-14 | Consonance Capital Management LP | ARQULE INC | 6,273,373 | 5.2% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | ARQULE INC | 5,917,567 | 4.9% | EDGAR |
| SC 13G/A | 2020-02-12 | INTEGRATED CORE STRATEGIES (US) LLC | ARQULE INC | 1,301,451 | 1.1% | EDGAR |
| SC 13G/A | 2020-02-10 | Nantahala Capital Management, LLC | ARQULE INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | ARQULE INC | 10,009,684 | 8.3% | EDGAR |
| SC 13G/A | 2020-01-10 | Nantahala Capital Management, LLC | ARQULE INC | 6,544,347 | 5.4% | EDGAR |
| SC 13G/A | 2020-01-09 | Bleichroeder LP | ARQULE INC | 2,750,000 | 2.3% | EDGAR |
| SC 13D | 2019-12-16 | Merck & Co., Inc. | ARQULE INC | 17,481,903 | 12.6% | EDGAR |
| SC 13D/A | 2019-09-19 | Pontifax Management 4 G.P. (2015) Ltd. | ARQULE INC | 1 | 7.4% | EDGAR |
| SC 13G/A | 2019-09-06 | Bleichroeder LP | ARQULE INC | 15,928,628 | 13.2% | EDGAR |
| SC 13G | 2019-09-05 | Bleichroeder LP | ARQULE INC | 15,928,628 | 13.2% | EDGAR |
| SC 13G/A | 2019-09-04 | First Eagle Investment Management, LLC | ARQULE INC | 0 | 0.0% | EDGAR |
| SC 13G | 2019-05-13 | INTEGRATED CORE STRATEGIES (US) LLC | ARQULE INC | 5,196,955 | 4.8% | EDGAR |
| SC 13G/A | 2019-03-18 | 1Globe Capital LLC | ARQULE INC | 426,501 | 0.4% | EDGAR |
| SC 13G/A | 2019-02-14 | BIOTECHNOLOGY VALUE FUND L P | ARQULE INC | 4,223,009 | 3.8% | EDGAR |
| SC 13G/A | 2019-02-14 | Nantahala Capital Management, LLC | ARQULE INC | 12,637,122 | 11.5% | EDGAR |
| SC 13G/A | 2019-02-11 | First Eagle Investment Management, LLC | ARQULE INC | 16,081,128 | 14.8% | EDGAR |